Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
1(7%)
Results Posted
27%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
5
36%
Ph phase_4
3
21%
Ph phase_2
2
14%
Ph phase_1
2
14%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (16.7%)
Phase 22 (16.7%)
Phase 43 (25.0%)
N/A5 (41.7%)

Trials by Status

completed1179%
terminated17%
recruiting17%
unknown17%

Recent Activity

1 active trials
Showing 5 of 14
recruitingphase_4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

NCT06709196
completedphase_4

The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine

NCT03746106
unknownnot_applicable

Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis

NCT01140516
terminatednot_applicable

S. Aureus Decolonization in HPN Patients.

NCT03173053
completednot_applicable

Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.

NCT04306731
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06709196Phase 4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Recruiting
NCT03746106Phase 4

The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine

Completed
NCT01140516Not Applicable

Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis

Unknown
NCT03173053Not Applicable

S. Aureus Decolonization in HPN Patients.

Terminated
NCT04306731Not Applicable

Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.

Completed
NCT03077711Phase 4

Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs

Completed
NCT02879981

A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis

Completed
NCT00380640Phase 2

The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa

Completed
NCT02902640

A Non-Interventional Safety Study of Balsamic Bactrim

Completed
NCT00014911Phase 2

Islet Transplantation for Type 1 Diabetes

Completed
NCT02188472Phase 1

Pentriox - Induction of Oxidative Stress

Completed
NCT00002283Not Applicable

A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Completed
NCT00002002Not Applicable

A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome

Completed
NCT00002120Phase 1

Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14